Kin sue state, distributor over side-effects of Iressa cancer drug

Kin sue state, distributor over side-effects of Iressa cancer drug

TOKYO, Japan - Akio Chikazawa speaks to reporters in Tokyo on Nov. 25 after filing a damages suit against the state and AstraZeneca K.K., the Osaka-based Japanese subsidiary of British pharmaceutical company AstraZeneca PLC, the maker and distributor of the lung cancer drug Iressa, for alleged failure to inform doctors of the risk of serious side-effects.

  • Product Code
  • ILEA001106636
  • Registered date
  • 2004/11/25 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2004 Kyodo News
  • Media size
  • 1864 × 1228 pixel
  • Resolution
  • dpi
  • Deployment size
  • 290.04(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Plaintiffs of Iressa cancer drug case

    Plaintiffs of Iressa cancer drug case

    TOKYO, Japan - Three deceased patients' relatives who sued the Japanese government and the Japanese unit of British pharmaceutical company AstraZeneca PLC, demanding compensation for the side effects caused by the lung cancer drug Iressa, walk to the Tokyo High Court on Nov. 15, 2011. The high court on the same day ruled the government and AstraZeneca K.K. are not responsible for damages, overturning a lower court ruling. The plaintiffs sought a combined 77 million yen in compensation. (Kyodo)
      AstraZeneca ordered to pay damages over side-effects of Iressa

      AstraZeneca ordered to pay damages over side-effects of Iressa

      OSAKA, Japan - Supporters of plaintiffs hold up banners in front of the Osaka District Court on Feb. 25, 2011, declaring victory in their case after the court ordered the Japan unit of British drugmaker AstraZeneca PLC to pay a total of 60.5 million yen to nine of 11 plaintiffs who sought compensation over side-effects caused by the lung cancer drug Iressa. (Kyodo)
        AstraZeneca ordered to pay damages over side-effects of Iressa

        AstraZeneca ordered to pay damages over side-effects of Iressa

        OSAKA, Japan - Hideki Shimizu (R), a plaintiff who demanded compensation over side effects caused by the lung cancer drug Iressa, speaks at a press conference in Osaka on Feb. 25, 2011, together with Akio Chikazawa, a plaintiff in a similar suit filed in Tokyo. The Osaka District Court the same day ordered the Japan unit of British drugmaker AstraZeneca PLC to pay a total of 60.5 million yen to nine out of 11 plaintiffs, including Shimizu. (Kyodo)